OBJECTIVE: To determine whether REM sleep without atonia (RSWA) during polysomnography (PSG) predicts phenoconversion in patients with idiopathic REM sleep behavior disorder (iRBD), a prodromal feature of a neurodegenerative disease. METHODS: We analyzed RSWA in 60 patients with iRBD, including manual phasic, tonic, and any muscle activity in the submentalis and anterior tibialis muscles and the automated REM atonia index in the submentals. We identified patients who developed parkinsonism or mild cognitive impairment (MCI) during at least 3 years of follow-up after PSG. Kaplan-Meier analysis was performed and receiver operator curves were calculated to determine RSWA cutoffs predicting faster phenoconversion. RESULTS: Twenty-six (43%) patients developed parkinsonism (n = 17) or MCI (n = 9). Phenoconverters were older at iRBD diagnosis (p = 0.02). Median time to phenoconversion was 3.9 ± 2.5 years. iRBD phenoconverters had significantly more RSWA at diagnosis. Phenoconversion risk from iRBD diagnosis was 20% and 35% at 3 and 5 years, respectively, with greater risk in patients with iRBD with >46.4% any combined RSWA, which increased further to 30% and 55% at 3 and 5 years for patients >65 years of age at diagnosis. CONCLUSIONS: Patients with iRBD with higher amounts of polysomnographic RSWA had a greater risk of developing Parkinson disease or MCI. Patients with older age and higher RSWA amounts had more rapid phenoconversion than younger patients with RBD. Our study suggests that RSWA is a potential biomarker for risk stratification of iRBD phenoconversion that could facilitate prognostication for patients with iRBD. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that for patients with iRBD, increased RSWA correlates with increased risk for developing parkinsonism or MCI.
OBJECTIVE: To determine whether REM sleep without atonia (RSWA) during polysomnography (PSG) predicts phenoconversion in patients with idiopathic REM sleep behavior disorder (iRBD), a prodromal feature of a neurodegenerative disease. METHODS: We analyzed RSWA in 60 patients with iRBD, including manual phasic, tonic, and any muscle activity in the submentalis and anterior tibialis muscles and the automated REM atonia index in the submentals. We identified patients who developed parkinsonism or mild cognitive impairment (MCI) during at least 3 years of follow-up after PSG. Kaplan-Meier analysis was performed and receiver operator curves were calculated to determine RSWA cutoffs predicting faster phenoconversion. RESULTS: Twenty-six (43%) patients developed parkinsonism (n = 17) or MCI (n = 9). Phenoconverters were older at iRBD diagnosis (p = 0.02). Median time to phenoconversion was 3.9 ± 2.5 years. iRBD phenoconverters had significantly more RSWA at diagnosis. Phenoconversion risk from iRBD diagnosis was 20% and 35% at 3 and 5 years, respectively, with greater risk in patients with iRBD with >46.4% any combined RSWA, which increased further to 30% and 55% at 3 and 5 years for patients >65 years of age at diagnosis. CONCLUSIONS:Patients with iRBD with higher amounts of polysomnographic RSWA had a greater risk of developing Parkinson disease or MCI. Patients with older age and higher RSWA amounts had more rapid phenoconversion than younger patients with RBD. Our study suggests that RSWA is a potential biomarker for risk stratification of iRBD phenoconversion that could facilitate prognostication for patients with iRBD. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that for patients with iRBD, increased RSWA correlates with increased risk for developing parkinsonism or MCI.
Authors: Alex Iranzo; José Luis Molinuevo; Joan Santamaría; Mónica Serradell; María José Martí; Francesc Valldeoriola; Eduard Tolosa Journal: Lancet Neurol Date: 2006-07 Impact factor: 44.182
Authors: Alex Iranzo; Eduard Tolosa; Ellen Gelpi; José Luis Molinuevo; Francesc Valldeoriola; Mónica Serradell; Raquel Sanchez-Valle; Isabel Vilaseca; Francisco Lomeña; Dolores Vilas; Albert Lladó; Carles Gaig; Joan Santamaria Journal: Lancet Neurol Date: 2013-04-03 Impact factor: 44.182
Authors: Stuart J McCarter; Erik K St Louis; Christopher L Boswell; Lucas G Dueffert; Nancy Slocumb; Bradley F Boeve; Michael H Silber; Eric J Olson; Timothy I Morgenthaler; Maja Tippmann-Peikert Journal: Sleep Med Date: 2014-06-23 Impact factor: 3.492
Authors: S Gilman; G K Wenning; P A Low; D J Brooks; C J Mathias; J Q Trojanowski; N W Wood; C Colosimo; A Dürr; C J Fowler; H Kaufmann; T Klockgether; A Lees; W Poewe; N Quinn; T Revesz; D Robertson; P Sandroni; K Seppi; M Vidailhet Journal: Neurology Date: 2008-08-26 Impact factor: 9.910
Authors: Stuart J McCarter; Tonette L Gehrking; Erik K St Louis; Mariana D Suarez; Bradley F Boeve; Michael H Silber; Phillip A Low; Wolfgang Singer Journal: Clin Auton Res Date: 2020-03-19 Impact factor: 4.435
Authors: Michelle F Devine; John C Feemster; Elizabeth A Lieske; Stuart J McCarter; David J Sandness; Tyler Steele; Paul C Timm; Jay Mandrekar; Bradley F Boeve; Michael H Silber; Divyanshu Dubey; Andrew McKeon; Erik K St Louis Journal: Sleep Date: 2022-02-14 Impact factor: 5.849
Authors: Chiara La Morgia; Martina Romagnoli; Fabio Pizza; Francesco Biscarini; Marco Filardi; Vincenzo Donadio; Michele Carbonelli; Giulia Amore; Jason C Park; Michele Tinazzi; Valerio Carelli; Rocco Liguori; Giuseppe Plazzi; Elena Antelmi Journal: Mov Disord Date: 2021-10-07 Impact factor: 9.698
Authors: Irene Rechichi; Antonella Iadarola; Maurizio Zibetti; Alessandro Cicolin; Gabriella Olmo Journal: Int J Environ Res Public Health Date: 2021-12-27 Impact factor: 3.390
Authors: Mo H Modarres; Jonathan E Elliott; Kristianna B Weymann; Dennis Pleshakov; Donald L Bliwise; Miranda M Lim Journal: Sensors (Basel) Date: 2021-12-22 Impact factor: 3.576
Authors: Mitchell G Miglis; Charles H Adler; Elena Antelmi; Dario Arnaldi; Luca Baldelli; Bradley F Boeve; Matteo Cesari; Irene Dall'Antonia; Nico J Diederich; Kathrin Doppler; Petr Dušek; Raffaele Ferri; Jean-François Gagnon; Ziv Gan-Or; Wiebke Hermann; Birgit Högl; Michele T Hu; Alex Iranzo; Annette Janzen; Anastasia Kuzkina; Jee-Young Lee; Klaus L Leenders; Simon J G Lewis; Claudio Liguori; Jun Liu; Christine Lo; Kaylena A Ehgoetz Martens; Jiri Nepozitek; Giuseppe Plazzi; Federica Provini; Monica Puligheddu; Michal Rolinski; Jan Rusz; Ambra Stefani; Rebekah L S Summers; Dallah Yoo; Jennifer Zitser; Wolfgang H Oertel Journal: Lancet Neurol Date: 2021-08 Impact factor: 44.182
Authors: Jeong Hun Yang; Sang Ho Choi; Mi Hyun Lee; Seong Min Oh; Jae-Won Choi; Jee Eun Park; Kwang Suk Park; Yu Jin Lee Journal: J Clin Sleep Med Date: 2021-03-01 Impact factor: 4.062
Authors: Cole D Stang; Aidan F Mullan; Mania Hajeb; Emanuele Camerucci; Pierpaolo Turcano; Peter Martin; Michelle M Mielke; Keith A Josephs; James H Bower; Erik K St Louis; Bradley F Boeve; Rodolfo Savica Journal: Ann Neurol Date: 2020-11-20 Impact factor: 11.274